A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Clinical trial NCT02791256 · TERMINATED

Trial details

NCT number: NCT02791256
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2005-06-01
Primary completion: 2008-06-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.